The DEA's marijuana rescheduling under the Controlled Substances Act remains stalled amid procedural hurdles, including the August 2025 retirement of its sole administrative law judge and a January 2025 interlocutory appeal that canceled hearings on the proposed shift from Schedule I to Schedule III. President Trump's December 18, 2025 executive order directed Attorney General Pam Bondi to expedite the process, echoing HHS's 2023 scientific recommendation, yet no final rule has appeared in the Federal Register. Rep. Steve Cohen's March 27 letter to Bondi and DEA Administrator Terry Cole demanded a timeline 99 days post-order, underscoring delays. Traders eye potential agency responses, ALJ appointments, or appeal withdrawals as key catalysts ahead of rulemaking deadlines.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten · Aktualisiert$285,678 Vol.

30. Juni
13%

31. Dezember
40%
$285,678 Vol.

30. Juni
13%

31. Dezember
40%
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Markt eröffnet: Feb 7, 2026, 5:04 PM ET
Resolver
0x65070BE91...The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Resolver
0x65070BE91...The DEA's marijuana rescheduling under the Controlled Substances Act remains stalled amid procedural hurdles, including the August 2025 retirement of its sole administrative law judge and a January 2025 interlocutory appeal that canceled hearings on the proposed shift from Schedule I to Schedule III. President Trump's December 18, 2025 executive order directed Attorney General Pam Bondi to expedite the process, echoing HHS's 2023 scientific recommendation, yet no final rule has appeared in the Federal Register. Rep. Steve Cohen's March 27 letter to Bondi and DEA Administrator Terry Cole demanded a timeline 99 days post-order, underscoring delays. Traders eye potential agency responses, ALJ appointments, or appeal withdrawals as key catalysts ahead of rulemaking deadlines.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen